←Back to Expert Scholars
Translational Medicine / 转化医学Immunotoxicology, Severe irAE Management
Kerry Reynolds
MD
🏢Massachusetts General Hospital🌐USA
Clinical Director Inpatient Oncology Services
50
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Kerry Reynolds directs the inpatient toxicity management program at MGH and has published extensively on severe irAE critical care, including ICU management of checkpoint inhibitor complications.
Share:
🧪Research Fields 研究领域
severe irAE critical care
IO pneumonitis
inpatient irAE management
IO nephritis
multidisciplinary toxicity teams
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Kerry Reynolds 的研究动态
Follow Kerry Reynolds's research updates
留下邮箱，当我们发布与 Kerry Reynolds（Massachusetts General Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment